Literature DB >> 23582321

Allostery in disease and in drug discovery.

Ruth Nussinov1, Chung-Jung Tsai.   

Abstract

Allostery is largely associated with conformational and functional transitions in individual proteins. This concept can be extended to consider the impact of conformational perturbations on cellular function and disease states. Here, we clarify the concept of allostery and how it controls physiological activities. We focus on the challenging questions of how allostery can both cause disease and contribute to development of new therapeutics. We aim to increase the awareness of the linkage between disease symptoms on the cellular level and specific aberrant allosteric actions on the molecular level and to emphasize the potential of allosteric drugs in innovative therapies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2013        PMID: 23582321     DOI: 10.1016/j.cell.2013.03.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  207 in total

1.  Detection of secondary binding sites in proteins using fragment screening.

Authors:  R Frederick Ludlow; Marcel L Verdonk; Harpreet K Saini; Ian J Tickle; Harren Jhoti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-11       Impact factor: 11.205

Review 2.  Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view.

Authors:  Shaoyong Lu; Hyunbum Jang; Shuo Gu; Jian Zhang; Ruth Nussinov
Journal:  Chem Soc Rev       Date:  2016-07-11       Impact factor: 54.564

3.  The structural basis for Ras activation of PI3Kα lipid kinase.

Authors:  Mingzhen Zhang; Hyunbum Jang; Ruth Nussinov
Journal:  Phys Chem Chem Phys       Date:  2019-06-05       Impact factor: 3.676

Review 4.  50 years of allosteric interactions: the twists and turns of the models.

Authors:  Jean-Pierre Changeux
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-23       Impact factor: 94.444

5.  Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

Authors:  Rami A Al-Horani; David Gailani; Umesh R Desai
Journal:  Thromb Res       Date:  2015-04-22       Impact factor: 3.944

Review 6.  Chemical probes and drug leads from advances in synthetic planning and methodology.

Authors:  Christopher J Gerry; Stuart L Schreiber
Journal:  Nat Rev Drug Discov       Date:  2018-04-13       Impact factor: 84.694

7.  Mutations in Antibody Fragments Modulate Allosteric Response Via Hydrogen-Bond Network Fluctuations.

Authors:  Amit Srivastava; Malgorzata B Tracka; Shahid Uddin; Jose Casas-Finet; Dennis R Livesay; Donald J Jacobs
Journal:  Biophys J       Date:  2016-05-10       Impact factor: 4.033

8.  Disordered allostery: lessons from glucocorticoid receptor.

Authors:  Hesam N Motlagh; Jeremy A Anderson; Jing Li; Vincent J Hilser
Journal:  Biophys Rev       Date:  2015-04-23

9.  Effect of CDR3 sequences and distal V gene residues in regulating TCR-MHC contacts and ligand specificity.

Authors:  Brian D Stadinski; Peter Trenh; Brian Duke; Priya G Huseby; Guoqi Li; Lawrence J Stern; Eric S Huseby
Journal:  J Immunol       Date:  2014-05-09       Impact factor: 5.422

10.  Dancing through Life: Molecular Dynamics Simulations and Network-Centric Modeling of Allosteric Mechanisms in Hsp70 and Hsp110 Chaperone Proteins.

Authors:  Gabrielle Stetz; Gennady M Verkhivker
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.